| Course | DDHA 8801 Building Healthcare Brand and Alliances |
|---|---|
| Week | Week 6 |
| Paper type | Doctoral discussion post with two replies |
| Length | About 600 words, 4 pages |
| Format | Discussion post, APA 7 citations |
| School | Walden University |
| Program | Doctor of Healthcare Administration (DHA) |
| Updated | October 2026 |
Free sample paper for DDHA 8801 Week 6
Week 6 Discussion: Promises Marketing Can Write and Operations Cannot Yet Keep
"Seen Within Five Business Days" Is Not Ready to Print: What the Clock Must Measure, Who Must Be Counted and Who Signs Before a Wait-Time Promise Goes Public
Bayshore Health should not publish its promise that new joint care patients will be seen within five business days, not yet. The composite system's positioning work points to speed as the ground its rivals have left open, and the marketing office has already drafted a billboard. But the clinics' median is eleven business days today, and the measurement behind any figure has not been settled. Publishing now would make a claim the service cannot keep.
A wait-time promise needs a clock with a settled start and stop. The start should be the moment Bayshore receives the request, whether a referral, a portal message or a call, not the moment a scheduler gets to it. The stop should be the date of the completed first visit, not the date of the first appointment offered, since an offer the patient cannot take is not access. The denominator must include everyone who asked, including people who gave up before being seen or went elsewhere, because a measure that counts only patients who were eventually seen will look best exactly when access is worst. And the reporting period has to be long enough that one quiet week cannot carry the claim; a calendar quarter, with every clinic reported separately, is the minimum. Murray and Berwick (2003), writing about access in primary care, showed why the choice of measure matters, favoring the third next available appointment over the first because single openings mislead. The same caution applies here.
Approval should come before the wording reaches the public, and one role should sign it. Marketing can draft the line, but the chief medical officer should sign that the clinics meet it, with the quality office supplying the quarterly data, because the claim is a statement about clinical operations. Prentice and Pizer (2007) found that longer outpatient waits were associated with worse outcomes for older veterans, which is a reminder that a wait-time promise is a clinical commitment as well as a marketing one.
Until the measure exists and the clinics meet it for two consecutive quarters, Bayshore can still say something true: that it is adding early and late appointments and will publish its waiting times when it can stand behind them. That sentence is weaker, but it is the strongest one available today.
Reply to Aurelio
Aurelio, you argued that a wait-time promise can be published as an aspiration, with "we aim to" in front of it, and that patients understand the difference. I am not sure they do. A patient who reads "we aim to see you within five days" and waits two weeks experiences the same broken promise as one who read a firmer claim. Keller et al. (2002) stress that a brand's points of difference must be credible and deliverable, and an aim the clinics miss most of the time undermines credibility faster than saying nothing. Would you publish the aim alongside the current median, so readers can see the gap?
Reply to Grace
Grace, you suggested the measure should start when the scheduler first contacts the patient, because requests sometimes arrive incomplete. I see the practical point, but I would keep the clock starting at receipt. If incomplete referrals are common, that is part of the access problem, and starting the clock later would hide it. A separate measure of how many requests arrive incomplete, and how long it takes to complete them, would show where the delay sits without excusing it.
References
Keller, K. L., Sternthal, B., & Tybout, A. (2002). Three questions you need to ask about your brand. Harvard Business Review, 80(9), 80-86.
Murray, M., & Berwick, D. M. (2003). Advanced access: Reducing waiting and delays in primary care. JAMA, 289(8), 1035-1040. https://doi.org/10.1001/jama.289.8.1035
Prentice, J. C., & Pizer, S. D. (2007). Delayed access to health care and mortality. Health Services Research, 42(2), 644-662. https://doi.org/10.1111/j.1475-6773.2006.00626.x
Reading the DDHA 8801 Week 6 instructions
This thread usually asks you to examine a promise that marketing could publish before the service can keep it. Take a side in your first paragraph. Choose a specific promise, such as a waiting-time claim, and say plainly whether your organization could publish it now. Define what the promise would require in measurement terms: when the clock starts and stops, who is counted in the denominator, including people who gave up, and how long the reporting period must be. Name the approval that must exist and the role that signs it. Close with what the organization can truthfully say in the meantime. In replies, engage classmates' proposals for softer wording or different measures, and test them against how patients would experience the promise.
How the DDHA 8801 Week 6 example is put together
The first paragraph states the position, gives the current median and notes the draft billboard. The second defines the clock from receipt of the request to the completed visit, a denominator that includes people who never got seen and a quarterly period by clinic, citing Murray and Berwick on how choice of access measure matters. The third assigns approval to the chief medical officer with data from the quality office and cites Prentice and Pizer to frame waiting as a clinical commitment. The fourth offers an honest interim sentence. The reply to Aurelio argues that an aim patients see broken undermines credibility and suggests publishing it with the current median. The reply to Grace keeps the clock at receipt and proposes a separate measure for incomplete requests.
Where the marks sit in the DDHA 8801 Week 6 rubric
Graders reward a clear position taken early. Measurement should be defined operationally, including start, stop, denominator and period, since vague definitions are where published claims go wrong. Naming the approval role shows understanding that access claims are clinical commitments. Evidence about why access measures and delays matter strengthens the post. A truthful interim alternative demonstrates judgment. Replies are evaluated on whether they test classmates' proposals against patient experience and keep the measure honest. Posts should be concise and cite sources accurately. A post that names the signer and the data source behind the signature shows a mature view of who owns public claims.
DDHA 8801 Week 6 help from the desk
Students often argue in general terms that marketing should be honest. Make it concrete: pick one promise and define the measure behind it. Decide when the clock starts and stops, and be suspicious of definitions that make performance look better. Include people who gave up. Say who signs. Offer something true to publish now. In replies, push back on wording that would still disappoint patients. If you want a post built around a promise your own organization is considering, we can draft one for your discussion. Before posting, check your measure against a bad week: would it still be honest if the clinic fell behind? If not, the definition is too generous.
Get a DDHA 8801 Week 6 example written to your instructions
Post the discussion instructions, the number of replies required and any article the thread points at, and what returns is an initial post with replies built to that shape. There is no charge for the first sample, and it arrives within 24 to 48 hours. Service data that has never left an organization is not something this desk collects.
More DDHA 8801 papers and DHA samples
- DDHA 8801 Week 1: Brand Promise Discussion Post
- DDHA 8801 Week 2: Market Analysis
- DDHA 8801 Week 3: Competitor Review
- DDHA 8801 Week 4: Audience Profile
- DDHA 8801 Week 5: Positioning Statement
- DDHA 8801 Week 7: Community Notice
- DDHA 8801 Week 8: Reputation Response
- DDHA 8801 Week 9: Due Diligence Memo
- DDHA 8801 Week 10: Alliance Governance
- DDHA 8801 Week 11: Alliance Case
- DDHA 8703 Week 6: Causal Claim Discussion Post
- DDHA 8601 Week 6: Interoperability Discussion Post
- DDHA 8503 Week 6: System Boundary Post
- DDHA 8303 Week 6: Single-Site Claims Post
DDHA 8801 Week 6 questions, answered
Where can I find a free DDHA 8801 Week 6 sample paper?
The access promise post and both replies, with references, are free to read here.
What promise does the DDHA 8801 Week 6 example say is not ready?
That new joint care patients will be seen within five business days, when the current median is eleven.
When should the waiting clock start and stop?
It starts when the request is received and stops at the completed first visit, not the first appointment offered.
Who should approve the published wording?
The chief medical officer, using quarterly data from the quality office, since the claim concerns clinical operations.
What can the system say meanwhile?
That it is adding early and late appointments and will publish waiting times once it can stand behind them.